What is HAE's current stock price?

As of now, HAE is trading at $80.75, with a daily change of +0.15%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

HAE Stock Analysis & IQ Rating | Haemonetics Corporat

HAE

Haemonetics Corporat

$80.75

+$0.12 | +0.15%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$89.69

MKT CAP

$3.73B

52W Low

$47.32

VOL

$415.21K

P/E Ratio

30.87

AVG VOL

$993.17K

RSI

87.14

TREND

Sideways

HAE Stock IQ

Login to see Haemonetics Corporat (HAE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

HAE Target Price

Login to display

Not Enough Information

Strengths

HAE Rewards

Upgraded on attractively valued

HAE Rewards

Earnings are forecast to grow

HAE Rewards

Trading below its fair value

Chart

$50.01 (+61.47%)

$54.38 (+48.49%)

$73.45 (+9.94%)

$82.25 (-1.82%)

1year

6month

3month

1month

HAE Risk Level

HAE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

HAE Analysts Opinion

HAE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

HAE Analysts Opinion

HAE Analysts opinion is positive but there was a setback from the past 3 months

HAE Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

82%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

100%

80%

HAE Street Sentiment

HAE Street Sentiment is extremely bullish and have positive views on the near-term outlook

HAE Performance Sentiment

Sentiments overview associated with HAE events and the stock performance.

82%

9%

Positive

Negative

9 out of 11
events present

1 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

HAE Latest Analysis +

Haemonetics Reaches Analyst Target Price. In recent trading shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $80.40 changing hands for $80.63/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on val

Wed Nov 26, 2025

$80.75 | +0.15%

Potential

Rating

Haemonetics (HAE) Price Target Increased by 11.07% to 88.03. The average one-year price target for Haemonetics (NYSE:HAE) has been revised to $88.03 / share. This is an increase of 11.07% from the prior estimate of $79.25 dated November 7 2025. The price target is an average of many targets provided by analysts. The la

Mon Nov 17, 2025

$74.32 | +1.13%

Potential

Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Thu Nov 13, 2025

$73.93 | +1.09%

Momentum

Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Tue Nov 11, 2025

$71.73 | +1.77%

Potential

Why Haemonetics Stock Was on Fire Thursday. Key PointsIt was something of an outlier in booking gains on a bearish day for stocks overall.

Fri Nov 7, 2025

$68.36 | +1.86%

Momentum

Haemonetics Is Still Undervalued Even After The Rally.

Fri Nov 7, 2025

$68.36 | +1.86%

Potential

Haemonetics raises 2026 guidance projects 7%–10% organic growth ex CSL amid strong plasma and hospital performance.

Fri Nov 7, 2025

$68.36 | +1.86%

Earnings

Potential

BTIG Maintains Haemonetics (HAE) Buy Recommendation. Fintel reports that on November 6 2025 BTIG maintained coverage of Haemonetics (NYSE:HAE) with a Buy recommendation. Analyst Price Forecast Suggests 17.96% Upside

Fri Nov 7, 2025

$68.36 | +1.86%

Rating

Haemonetics Corp Bottom Line Climbs In Q2 . (RTTNews) - Haemonetics Corp (HAE) revealed a profit for its second quarter that Increases from last year

Fri Nov 7, 2025

$68.36 | +1.86%

Momentum

FAQ About HAE Stock Insights

What is HAE current stock price?

What are HAE stock strengths?

What is HAE Risk Level?

What is HAE market cap and volume?

What is HAE current Stock IQ?

Should I buy HAE stock right now?

Is HAE a Strong Buy right now?

What does a 'Strong Buy' rating mean for HAE?

What does a 'Strong Sell' rating mean for HAE?

What factors influence HAE's Stock IQ?

Explore our HAE Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored HAE Stock Strategies
Effective Risk Management

FIND US ON

Receive our HAE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

HAE

Haemonetics Corporat

Current Price

$80.75

+$0.12 | +0.15%

52W High

$89.69

MKT CAP

$3.73B

52W Low

$47.32

VOL

$415.21K

P/E Ratio

30.87

AVG VOL

$993.17K

RSI

87.14

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

HAE Rewards

Upgraded on attractively valued

HAE Rewards

Earnings are forecast to grow

HAE Rewards

Trading below its fair value

HAE Stock IQ

Login to unlock Haemonetics Corporat (HAE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$50.01 (+61.47%)

$54.38 (+48.49%)

$73.45 (+9.94%)

$82.25 (-1.82%)

1year

6month

3month

1month

HAE Analysts Opinion

HAE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

HAE Analysts Opinion

HAE Analysts opinion is positive but there was a setback from the past 3 months

HAE Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

82%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

100%

80%

HAE Street Sentiment

HAE Street Sentiment is extremely bullish and have positive views on the near-term outlook

HAE Risk Level

HAE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

HAE Performance Sentiment

Sentiments overview associated with HAE events and the stock performance.

82%

9%

Positive

Negative

9 out of 11
events present

1 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

HAE Latest Analysis

Haemonetics Reaches Analyst Target Price. In recent trading shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $80.40 changing hands for $80.63/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on val

Wed Nov 26, 2025

$80.75 | +0.15%

Potential

Rating

Haemonetics (HAE) Price Target Increased by 11.07% to 88.03. The average one-year price target for Haemonetics (NYSE:HAE) has been revised to $88.03 / share. This is an increase of 11.07% from the prior estimate of $79.25 dated November 7 2025. The price target is an average of many targets provided by analysts. The la

Mon Nov 17, 2025

$74.32 | +1.13%

Potential

Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Thu Nov 13, 2025

$73.93 | +1.09%

Momentum

Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Tue Nov 11, 2025

$71.73 | +1.77%

Potential

Why Haemonetics Stock Was on Fire Thursday. Key PointsIt was something of an outlier in booking gains on a bearish day for stocks overall.

Fri Nov 7, 2025

$68.36 | +1.86%

Momentum

Haemonetics Is Still Undervalued Even After The Rally.

Fri Nov 7, 2025

$68.36 | +1.86%

Potential

Haemonetics raises 2026 guidance projects 7%–10% organic growth ex CSL amid strong plasma and hospital performance.

Fri Nov 7, 2025

$68.36 | +1.86%

Earnings

Potential

BTIG Maintains Haemonetics (HAE) Buy Recommendation. Fintel reports that on November 6 2025 BTIG maintained coverage of Haemonetics (NYSE:HAE) with a Buy recommendation. Analyst Price Forecast Suggests 17.96% Upside

Fri Nov 7, 2025

$68.36 | +1.86%

Rating

Haemonetics Corp Bottom Line Climbs In Q2 . (RTTNews) - Haemonetics Corp (HAE) revealed a profit for its second quarter that Increases from last year

Fri Nov 7, 2025

$68.36 | +1.86%

Momentum

Discover HAE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of HAE. We're here to help you make informed investment decisions today.

FIND US ON

Receive our HAE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

HAE Stock trends

HAE Stock performance

HAE Stock analysis

HAE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing HAE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing HAE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

HAE Stock Analysis & IQ Rating | Haemonetics Corporat

HAE Stock IQ

HAE Target Price

HAE Risk Level

HAE Analysts Opinion

HAE Street Sentiment

HAE Performance Sentiment

Explore our HAE Stock insights

Receive our HAE Daily Alerts

HAE Stock IQ

HAE Street Sentiment

HAE Risk Level

Discover HAE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of HAE. We're here to help you make informed investment decisions today.

Receive our HAE Daily Alerts

HAE Runner Alarm